市場調査レポート
商品コード
1338157

ワクチン研究の世界市場 2023-2027

Global Vaccine Research Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 160 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
ワクチン研究の世界市場 2023-2027
出版日: 2023年07月07日
発行: TechNavio
ページ情報: 英文 160 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ワクチン研究市場は2022-2027年に175億9,000万米ドル、予測期間中のCAGRは9.88%で成長すると予測されます。

当レポートでは、ワクチン研究市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、感染症の高い流行、慢性感染症に対する新規ワクチンのニーズ、アジュバントとワクチンデリバリーシステムが牽引しています。

本調査では、今後数年間のワクチン研究市場成長を牽引する主な要因の一つとして、ワクチンの研究開発を加速するためのAIの採用を挙げています。また、高所得国や新興国におけるワクチン需要の変動や、新規ワクチンの研究開発の活発化も、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し 2022-2027

第4章 市場規模実績

  • 世界のワクチン研究市場 2017-2021
  • エンドユーザー別セグメント分析 2017-2021
  • 年齢層別セグメント分析 2017-2021
  • 地域別セグメント分析 2017-2021
  • 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 公共:市場規模と予測 2022-2027
  • 民間:市場規模と予測 2022-2027
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:年齢層別

  • 市場セグメント
  • 比較:年齢層別
  • 小児:市場規模と予測 2022-2027
  • 成人:市場規模と予測 2022-2027
  • 市場機会:年齢層別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2022-2027
  • 欧州:市場規模と予測 2022-2027
  • アジア:市場規模と予測 2022-2027
  • 世界のその他の地域:市場規模と予測 2022-2027
  • 米国:市場規模と予測 2022-2027
  • ドイツ:市場規模と予測 2022-2027
  • 英国:市場規模と予測 2022-2027
  • 中国:市場規模と予測 2022-2027
  • カナダ:市場規模と予測 2022-2027
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CanSino Biologics Inc.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
  • Exhibits19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
  • Exhibits20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
  • Exhibits35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
  • Exhibits36: Chart on Public - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Public - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
  • Exhibits39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
  • Exhibits40: Chart on Private - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Private - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by End-user ($ billion)
  • Exhibits43: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits44: Chart on Age Group - Market share 2022-2027 (%)
  • Exhibits45: Data Table on Age Group - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by Age Group
  • Exhibits47: Data Table on Comparison by Age Group
  • Exhibits48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
  • Exhibits49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
  • Exhibits50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
  • Exhibits53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
  • Exhibits54: Chart on Adult - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Market opportunity by Age Group ($ billion)
  • Exhibits57: Data Table on Market opportunity by Age Group ($ billion)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits101: Impact of drivers and challenges in 2022 and 2027
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Abbott Laboratories - Overview
  • Exhibits108: Abbott Laboratories - Business segments
  • Exhibits109: Abbott Laboratories - Key news
  • Exhibits110: Abbott Laboratories - Key offerings
  • Exhibits111: Abbott Laboratories - Segment focus
  • Exhibits112: Astellas Pharma Inc. - Overview
  • Exhibits113: Astellas Pharma Inc. - Product / Service
  • Exhibits114: Astellas Pharma Inc. - Key news
  • Exhibits115: Astellas Pharma Inc. - Key offerings
  • Exhibits116: AstraZeneca Plc - Overview
  • Exhibits117: AstraZeneca Plc - Product / Service
  • Exhibits118: AstraZeneca Plc - Key news
  • Exhibits119: AstraZeneca Plc - Key offerings
  • Exhibits120: Bavarian Nordic AS - Overview
  • Exhibits121: Bavarian Nordic AS - Product / Service
  • Exhibits122: Bavarian Nordic AS - Key offerings
  • Exhibits123: Bharat Biotech Ltd. - Overview
  • Exhibits124: Bharat Biotech Ltd. - Product / Service
  • Exhibits125: Bharat Biotech Ltd. - Key news
  • Exhibits126: Bharat Biotech Ltd. - Key offerings
  • Exhibits127: CanSino Biologics Inc. - Overview
  • Exhibits128: CanSino Biologics Inc. - Product / Service
  • Exhibits129: CanSino Biologics Inc. - Key offerings
  • Exhibits130: CSL Ltd. - Overview
  • Exhibits131: CSL Ltd. - Business segments
  • Exhibits132: CSL Ltd. - Key news
  • Exhibits133: CSL Ltd. - Key offerings
  • Exhibits134: CSL Ltd. - Segment focus
  • Exhibits135: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits136: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibits137: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits138: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits139: Emergent BioSolutions Inc. - Overview
  • Exhibits140: Emergent BioSolutions Inc. - Product / Service
  • Exhibits141: Emergent BioSolutions Inc. - Key news
  • Exhibits142: Emergent BioSolutions Inc. - Key offerings
  • Exhibits143: GlaxoSmithKline Plc - Overview
  • Exhibits144: GlaxoSmithKline Plc - Business segments
  • Exhibits145: GlaxoSmithKline Plc - Key news
  • Exhibits146: GlaxoSmithKline Plc - Key offerings
  • Exhibits147: GlaxoSmithKline Plc - Segment focus
  • Exhibits148: Johnson and Johnson Services Inc. - Overview
  • Exhibits149: Johnson and Johnson Services Inc. - Business segments
  • Exhibits150: Johnson and Johnson Services Inc. - Key news
  • Exhibits151: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits152: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits153: Merck and Co. Inc. - Overview
  • Exhibits154: Merck and Co. Inc. - Business segments
  • Exhibits155: Merck and Co. Inc. - Key news
  • Exhibits156: Merck and Co. Inc. - Key offerings
  • Exhibits157: Merck and Co. Inc. - Segment focus
  • Exhibits158: Novavax Inc. - Overview
  • Exhibits159: Novavax Inc. - Product / Service
  • Exhibits160: Novavax Inc. - Key offerings
  • Exhibits161: Panacea Biotec Ltd. - Overview
  • Exhibits162: Panacea Biotec Ltd. - Product / Service
  • Exhibits163: Panacea Biotec Ltd. - Key offerings
  • Exhibits164: Pfizer Inc. - Overview
  • Exhibits165: Pfizer Inc. - Product / Service
  • Exhibits166: Pfizer Inc. - Key news
  • Exhibits167: Pfizer Inc. - Key offerings
  • Exhibits168: Inclusions checklist
  • Exhibits169: Exclusions checklist
  • Exhibits170: Currency conversion rates for US$
  • Exhibits171: Research methodology
  • Exhibits172: Validation techniques employed for market sizing
  • Exhibits173: Information sources
  • Exhibits174: List of abbreviations
目次
Product Code: IRTNTR71157

The vaccine research market is forecasted to grow by USD 17.59 bn during 2022-2027, accelerating at a CAGR of 9.88% during the forecast period. The report on the vaccine research market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of infectious diseases, need for novel vaccines for chronic infections, and adjuvants and vaccine delivery systems.

Technavio's vaccine research market is segmented as below:

By End-user

  • Public
  • Private

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the adoption of ai to speed up the R and D of vaccines as one of the prime reasons driving the vaccine research market growth during the next few years. Also, fluctuations in demand for vaccines in high-income and developing countries and rising R and D of novel vaccines will lead to sizable demand in the market.

The report on the vaccine research market covers the following areas:

  • Vaccine research market sizing
  • Vaccine research market forecast
  • Vaccine research market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccine research market vendors that include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene. Also, the vaccine research market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global vaccine research market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
  • 4.2 End-User Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
  • 4.3 Age Group Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Public - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on Public - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Public - Year-over-year growth 2022-2027 (%)
  • 6.4 Private - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on Private - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Private - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by End-user
  • Exhibit 42: Market opportunity by End-user ($ billion)
  • Exhibit 43: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Age Group

  • 7.1 Market segments
  • Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
  • 7.2 Comparison by Age Group
  • Exhibit 46: Chart on Comparison by Age Group
  • Exhibit 47: Data Table on Comparison by Age Group
  • 7.3 Pediatric - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
  • 7.4 Adult - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Age Group
  • Exhibit 56: Market opportunity by Age Group ($ billion)
  • Exhibit 57: Data Table on Market opportunity by Age Group ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 107: Abbott Laboratories - Overview
  • Exhibit 108: Abbott Laboratories - Business segments
  • Exhibit 109: Abbott Laboratories - Key news
  • Exhibit 110: Abbott Laboratories - Key offerings
  • Exhibit 111: Abbott Laboratories - Segment focus
  • 12.4 Astellas Pharma Inc.
  • Exhibit 112: Astellas Pharma Inc. - Overview
  • Exhibit 113: Astellas Pharma Inc. - Product / Service
  • Exhibit 114: Astellas Pharma Inc. - Key news
  • Exhibit 115: Astellas Pharma Inc. - Key offerings
  • 12.5 AstraZeneca Plc
  • Exhibit 116: AstraZeneca Plc - Overview
  • Exhibit 117: AstraZeneca Plc - Product / Service
  • Exhibit 118: AstraZeneca Plc - Key news
  • Exhibit 119: AstraZeneca Plc - Key offerings
  • 12.6 Bavarian Nordic AS
  • Exhibit 120: Bavarian Nordic AS - Overview
  • Exhibit 121: Bavarian Nordic AS - Product / Service
  • Exhibit 122: Bavarian Nordic AS - Key offerings
  • 12.7 Bharat Biotech Ltd.
  • Exhibit 123: Bharat Biotech Ltd. - Overview
  • Exhibit 124: Bharat Biotech Ltd. - Product / Service
  • Exhibit 125: Bharat Biotech Ltd. - Key news
  • Exhibit 126: Bharat Biotech Ltd. - Key offerings
  • 12.8 CanSino Biologics Inc.
  • Exhibit 127: CanSino Biologics Inc. - Overview
  • Exhibit 128: CanSino Biologics Inc. - Product / Service
  • Exhibit 129: CanSino Biologics Inc. - Key offerings
  • 12.9 CSL Ltd.
  • Exhibit 130: CSL Ltd. - Overview
  • Exhibit 131: CSL Ltd. - Business segments
  • Exhibit 132: CSL Ltd. - Key news
  • Exhibit 133: CSL Ltd. - Key offerings
  • Exhibit 134: CSL Ltd. - Segment focus
  • 12.10 Daiichi Sankyo Co. Ltd.
  • Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibit 136: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings
  • 12.11 Emergent BioSolutions Inc.
  • Exhibit 139: Emergent BioSolutions Inc. - Overview
  • Exhibit 140: Emergent BioSolutions Inc. - Product / Service
  • Exhibit 141: Emergent BioSolutions Inc. - Key news
  • Exhibit 142: Emergent BioSolutions Inc. - Key offerings
  • 12.12 GlaxoSmithKline Plc
  • Exhibit 143: GlaxoSmithKline Plc - Overview
  • Exhibit 144: GlaxoSmithKline Plc - Business segments
  • Exhibit 145: GlaxoSmithKline Plc - Key news
  • Exhibit 146: GlaxoSmithKline Plc - Key offerings
  • Exhibit 147: GlaxoSmithKline Plc - Segment focus
  • 12.13 Johnson and Johnson Services Inc.
  • Exhibit 148: Johnson and Johnson Services Inc. - Overview
  • Exhibit 149: Johnson and Johnson Services Inc. - Business segments
  • Exhibit 150: Johnson and Johnson Services Inc. - Key news
  • Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
  • Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
  • 12.14 Merck and Co. Inc.
  • Exhibit 153: Merck and Co. Inc. - Overview
  • Exhibit 154: Merck and Co. Inc. - Business segments
  • Exhibit 155: Merck and Co. Inc. - Key news
  • Exhibit 156: Merck and Co. Inc. - Key offerings
  • Exhibit 157: Merck and Co. Inc. - Segment focus
  • 12.15 Novavax Inc.
  • Exhibit 158: Novavax Inc. - Overview
  • Exhibit 159: Novavax Inc. - Product / Service
  • Exhibit 160: Novavax Inc. - Key offerings
  • 12.16 Panacea Biotec Ltd.
  • Exhibit 161: Panacea Biotec Ltd. - Overview
  • Exhibit 162: Panacea Biotec Ltd. - Product / Service
  • Exhibit 163: Panacea Biotec Ltd. - Key offerings
  • 12.17 Pfizer Inc.
  • Exhibit 164: Pfizer Inc. - Overview
  • Exhibit 165: Pfizer Inc. - Product / Service
  • Exhibit 166: Pfizer Inc. - Key news
  • Exhibit 167: Pfizer Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 168: Inclusions checklist
  • Exhibit 169: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 170: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 171: Research methodology
  • Exhibit 172: Validation techniques employed for market sizing
  • Exhibit 173: Information sources
  • 13.5 List of abbreviations
  • Exhibit 174: List of abbreviations